![Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data - The Lancet Global Health Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data - The Lancet Global Health](https://www.thelancet.com/cms/attachment/f45f2a81-e197-47d0-801b-69d572a2361d/gr1.jpg)
Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data - The Lancet Global Health
![Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet](https://www.thelancet.com/cms/asset/039ffa3b-dbf8-4070-bb79-bf7c71cf9521/gr1a.jpg)
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet
![Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England | Nature Communications Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-32121-6/MediaObjects/41467_2022_32121_Fig1_HTML.png)